Verition Fund Management
GRCL

Verition Fund Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Verition Fund Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-86,644
Closed -$250K – 2302
2023
Q3 		$250K Buy
+86,644
New +$250K ﹤0.01% 1515